{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:31:13Z","timestamp":1791261073074,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011755","name":"National Center for Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005632","name":"National Centre for Research and Development","doi-asserted-by":"publisher","award":["LIDER\/22\/0122\/L-10\/18\/NCBR\/2019"],"award-info":[{"award-number":["LIDER\/22\/0122\/L-10\/18\/NCBR\/2019"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jpet.2025.103772","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T08:54:50Z","timestamp":1762764890000},"page":"103772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting of Brahma-related gene-1 (BRG1) overcomes paclitaxel-induced multidrug resistance caused by overexpression of the subset of ATP-binding cassette (ABC) transporters"],"prefix":"10.1016","volume":"392","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9121-3700","authenticated-orcid":false,"given":"Karolina","family":"Gronkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8952-469X","authenticated-orcid":false,"given":"Sylwia","family":"Michlewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"P\u0142oszaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Strachowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna","family":"St\u0119pie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Borowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4570-4154","authenticated-orcid":false,"given":"Andrzej","family":"Bednarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6265-5585","authenticated-orcid":false,"given":"Agnieszka","family":"Robaszkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpet.2025.103772_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100742","article-title":"Taxanes in cancer treatment: activity, chemoresistance and its overcoming","volume":"54","author":"Mosca","year":"2021","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jpet.2025.103772_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/413076","article-title":"Paclitaxel and its evolving role in the management of ovarian cancer","volume":"2015","author":"Kampan","year":"2015","journal-title":"Biomed Res Int"},{"issue":"1","key":"10.1016\/j.jpet.2025.103772_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s10020-020-00152-8","article-title":"Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer","volume":"26","author":"Zang","year":"2020","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.jpet.2025.103772_bib4","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/21691401.2020.1728287","article-title":"KANK1 regulates paclitaxel resistance in lung adenocarcinoma A549 cells","volume":"48","author":"Pu","year":"2020","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"11","key":"10.1016\/j.jpet.2025.103772_bib5","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3390\/cancers12113323","article-title":"Mechanisms of taxane resistance","volume":"12","author":"Maloney","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.jpet.2025.103772_bib6","first-page":"569","article-title":"Current perspectives on taxanes: focus on their bioactivity, delivery and combination therapy","volume":"10","author":"\u0160kubn\u00edk","year":"2021","journal-title":"Plants (Basel)"},{"issue":"12","key":"10.1016\/j.jpet.2025.103772_bib7","article-title":"Molecular and cellular paradigms of multidrug resistance in cancer","volume":"5","author":"Vaidya","year":"2022","journal-title":"Cancer Rep"},{"issue":"10","key":"10.1016\/j.jpet.2025.103772_bib8","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.21873\/anticanres.13739","article-title":"Apatinib reverses paclitaxel-resistant lung cancer cells (A549) through blocking the function of ABCB1 transporter","volume":"39","author":"Zhang","year":"2019","journal-title":"Anticancer Res"},{"issue":"5","key":"10.1016\/j.jpet.2025.103772_bib9","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1158\/1535-7163.MCT-07-2088","article-title":"MRP7\/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer","volume":"7","author":"Oguri","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"10.1016\/j.jpet.2025.103772_bib10","doi-asserted-by":"crossref","first-page":"16624","DOI":"10.3390\/ijms131216624","article-title":"Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure","volume":"13","author":"Melguizo","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.jpet.2025.103772_bib11","first-page":"5363","article-title":"Resveratrol augments paclitaxel treatment in MDA-MB-231 and paclitaxel-resistant MDA-MB-231 breast cancer cells","volume":"34","author":"Sprouse","year":"2014","journal-title":"Anticancer Res"},{"issue":"8","key":"10.1016\/j.jpet.2025.103772_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254205","article-title":"Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer","volume":"16","author":"McCorkle","year":"2021","journal-title":"PLOS One"},{"issue":"3","key":"10.1016\/j.jpet.2025.103772_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.53","article-title":"The FOXM1\u2013ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells","volume":"8","author":"Hou","year":"2017","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.jpet.2025.103772_bib14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.33594\/000000663","article-title":"Activity of lysosomal ABCC3, ABCC5 and ABCC10 is responsible for lysosomal sequestration of doxorubicin and paclitaxel-oregongreen488 in paclitaxel-resistant cancer cell lines","volume":"57","author":"Gronkowska","year":"2023","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1016\/j.jpet.2025.103772_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3032590","article-title":"FOXM1 promotes drug resistance in cervical cancer cells by regulating ABCC5 gene transcription","volume":"2022","author":"Hou","year":"2022","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jpet.2025.103772_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.omto.2019.05.005","article-title":"FoxM1 induced paclitaxel resistance via activation of the FoxM1\/PHB1\/RAF-MEK-ERK pathway and enhancement of the ABCA2 transporter","volume":"14","author":"Huang","year":"2019","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.jpet.2025.103772_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.gene.2018.04.033","article-title":"HOXB4 knockdown enhances the cytotoxic effect of paclitaxel and cisplatin by downregulating ABC transporters in ovarian cancer cells","volume":"663","author":"Li","year":"2018","journal-title":"Gene"},{"issue":"3","key":"10.1016\/j.jpet.2025.103772_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/mc.23148","article-title":"SOX2 upregulates side population cells and enhances their chemoresistant ability by transactivating ABCC1 expression contributing to intrinsic resistance to paclitaxel in melanoma","volume":"59","author":"Si","year":"2020","journal-title":"Mol Carcinog"},{"issue":"1","key":"10.1016\/j.jpet.2025.103772_bib19","doi-asserted-by":"crossref","first-page":"9170","DOI":"10.1038\/s41598-017-08971-2","article-title":"Modulation of SOX2 expression delineates an end-point for paclitaxel-effectiveness in breast cancer stem cells","volume":"7","author":"Mukherjee","year":"2017","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.jpet.2025.103772_bib20","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1111\/cas.15448","article-title":"H1.0 induces paclitaxel-resistance genes expression in ovarian cancer cells by recruiting GCN5 and androgen receptor","volume":"113","author":"Kohli","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jpet.2025.103772_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115798","article-title":"I-CBP112 declines overexpression of ATP-binding cassette transporters and sensitized drug-resistant MDA-MB-231 and A549 cell lines to chemotherapy drugs","volume":"168","author":"Strachowska","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.jpet.2025.103772_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbagrm.2018.10.019","article-title":"EP300-HDAC1-SWI\/SNF functional unit defines transcription of some DNA repair enzymes during differentiation of human macrophages","volume":"1862","author":"Pietrzak","year":"2019","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"issue":"2","key":"10.1016\/j.jpet.2025.103772_bib23","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3390\/cancers12020349","article-title":"BRG1 activates proliferation and transcription of cell cycle-dependent genes in breast cancer cells","volume":"12","author":"Sobczak","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"19","key":"10.1016\/j.jpet.2025.103772_bib24","doi-asserted-by":"crossref","first-page":"27158","DOI":"10.18632\/oncotarget.8384","article-title":"Targeting the chromatin remodeling enzyme BRG1 increases the efficacy of chemotherapy drugs in breast cancer cells","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.jpet.2025.103772_bib25","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2217\/epi-2017-0034","article-title":"The BRG1 ATPase of human SWI\/SNF chromatin remodeling enzymes as a driver of cancer","volume":"9","author":"Wu","year":"2017","journal-title":"Epigenomics"},{"issue":"4","key":"10.1016\/j.jpet.2025.103772_bib26","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/cancers14040894","article-title":"Activation of ABCC genes by cisplatin depends on the CoREST occurrence at their promoters in A549 and MDA-MB-231 cell lines","volume":"14","author":"Sobczak","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.jpet.2025.103772_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-10307-z","article-title":"Downregulation of PARP1 transcription by promoter-associated E2F4-RBL2-HDAC1-BRM complex contributes to repression of pluripotency stem cell factors in human monocytes","volume":"7","author":"Wi\u015bnik","year":"2017","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.jpet.2025.103772_bib28","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.3390\/cancers13184614","article-title":"CBP\/p300 bromodomain inhibitor-I-CBP112 declines transcription of the key ABC transporters and sensitizes cancer cells to chemotherapy drugs","volume":"13","author":"Strachowska","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"W1","key":"10.1016\/j.jpet.2025.103772_bib29","doi-asserted-by":"crossref","first-page":"W345","DOI":"10.1093\/nar\/gkac247","article-title":"The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update","volume":"50","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.jpet.2025.103772_bib30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/jcp.25596","article-title":"Identifying nuclear matrix-attached DNA across the genome","volume":"232","author":"Dobson","year":"2017","journal-title":"J Cell Physiol"},{"issue":"1","key":"10.1016\/j.jpet.2025.103772_bib31","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1038\/s41598-019-45839-z","article-title":"The ENCODE blacklist: identification of problematic regions of the genome","volume":"9","author":"Amemiya","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jpet.2025.103772_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/path.4926","article-title":"SMARCA4 inactivating mutations cause concomitant Coffin\u2013Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type","volume":"243","author":"Errichiello","year":"2017","journal-title":"J Pathol"},{"issue":"10","key":"10.1016\/j.jpet.2025.103772_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048745","article-title":"Reanalysis of RNA-sequencing data reveals several additional fusion genes with multiple isoforms","volume":"7","author":"Kangaspeska","year":"2012","journal-title":"PLOS One"},{"issue":"21","key":"10.1016\/j.jpet.2025.103772_bib34","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1038\/s41388-021-01781-x","article-title":"Exploiting vulnerabilities of SWI\/SNF chromatin remodelling complexes for cancer therapy","volume":"40","author":"Wanior","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.jpet.2025.103772_bib35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.20892\/j.issn.2095-3941.2019.0284","article-title":"ABC transporters and the hallmarks of cancer: roles in cancer aggressiveness beyond multidrug resistance","volume":"17","author":"Muriithi","year":"2020","journal-title":"Cancer Biol Med"},{"issue":"7","key":"10.1016\/j.jpet.2025.103772_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2011.61","article-title":"Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters","volume":"2","author":"Saxena","year":"2011","journal-title":"Cell Death Dis"},{"issue":"28","key":"10.1016\/j.jpet.2025.103772_bib37","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.15155","article-title":"Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis","volume":"8","author":"Zhitomirsky","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpet.2025.103772_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.21037\/dmr.2018.09.03","article-title":"TFEB, a master regulator of lysosome biogenesis and autophagy, is a new player in alcoholic liver disease","volume":"1","author":"Bala","year":"2018","journal-title":"Dig Med Res"},{"issue":"19","key":"10.1016\/j.jpet.2025.103772_bib39","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.3390\/cells11193153","article-title":"TFEB; Beyond its role as an autophagy and lysosomes regulator","volume":"11","author":"Franco-Ju\u00e1rez","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.jpet.2025.103772_bib40","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/1541-7786.MCR-20-0289","article-title":"The bromodomain inhibitor PFI-3 sensitizes cancer cells to DNA damage by targeting SWI\/SNF","volume":"19","author":"Lee","year":"2021","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jpet.2025.103772_bib41","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/stem.2909","article-title":"Chromatin remodeling factor BRG1 regulates stemness and chemosensitivity of glioma initiating cells","volume":"36","author":"Ganguly","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.jpet.2025.103772_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116533","article-title":"Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI\/SNF complex increase the activity of temozolomide in glioblastoma cells","volume":"53","author":"He","year":"2022","journal-title":"Bioorg Med Chem"},{"issue":"5","key":"10.1016\/j.jpet.2025.103772_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251354","article-title":"Altering mammalian transcription networking with ADAADi: An inhibitor of ATP-dependent chromatin remodeling","volume":"16","author":"Rakesh","year":"2021","journal-title":"PLOS One"},{"issue":"7","key":"10.1016\/j.jpet.2025.103772_bib44","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41589-019-0294-6","article-title":"BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design","volume":"15","author":"Farnaby","year":"2019","journal-title":"Nat Chem Biol"},{"issue":"2","key":"10.1016\/j.jpet.2025.103772_bib45","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3892\/or.2021.8251","article-title":"Lysosome-targeted drug combination induces multiple organelle dysfunctions and non-canonical death in pancreatic cancer cells","volume":"47","author":"Suzuki","year":"2022","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.jpet.2025.103772_bib46","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.3390\/ijms24032176","article-title":"Lysosomes as a target of anticancer therapy","volume":"24","author":"Trybus","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2025.103772_bib47","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.2147\/IJN.S321343","article-title":"Novel approaches of dysregulating lysosome functions in cancer cells by specific drugs and its nanoformulations: a smart approach of modern therapeutics","volume":"16","author":"Allemailem","year":"2021","journal-title":"Int J Nanomedicine"},{"issue":"21","key":"10.1016\/j.jpet.2025.103772_bib48","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/j.jpet.2025.103772_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41389-019-0174-7","article-title":"Epigenetic regulation of lung cancer cell proliferation and migration by the chromatin remodeling protein BRG1","volume":"8","author":"Li","year":"2019","journal-title":"Oncogenesis"},{"key":"10.1016\/j.jpet.2025.103772_bib50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-arplant-102820-093218","article-title":"The role and activity of SWI\/SNF chromatin remodelers","volume":"74","author":"Bieluszewski","year":"2023","journal-title":"Annu Rev Plant Biol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356525402857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:01:56Z","timestamp":1777420916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356525402857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0022356525402857"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103772","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting of Brahma-related gene-1 (BRG1) overcomes paclitaxel-induced multidrug resistance caused by overexpression of the subset of ATP-binding cassette (ABC) transporters","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2025.103772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103772"}}